Neurolens and VisionWeb have worked together to expand the prism field from 1/4th prism diopter to 1/100th prism diopter when placing orders through VisionWeb’s ordering platform.
Ongoing research from a myriad of sources has indicated that at least two out of three patients experience the symptoms of eye misalignment, and the rapid acceleration in remote working and learning over the past 2 years has led to a rise in this figure, according to a Neurolens news release. Optical Prisms are one of the most commonly employed treatment modalities to correct these binocular vision issues. As such, technological innovations in this space will become increasingly important to the future of eyecare.
“At Neurolens, we strongly believe that the eyecare industry must evolve beyond visual acuity to own the visual comfort space as well,” Pierre Bertrand, Chief Executive Officer of Neurolens, said in a company news release. “A large and growing percentage of the population is suffering from the symptoms of binocular vision issues—some on a daily basis—and Neurolenses provide proven relief for these patients. We are proud to collaborate with an industry leader like VisionWeb to ensure that eye care providers can prescribe optical prism to the specificity required to meet the needs of today’s patients.”
This expanded prism range will allow Neurolens providers to take advantage of the accurate measurements from the Neurolens Measurement Device (NMD) and Neurolens Measurement Device, Gen 2 (NMD2) and prescribe precise prism measurements for their patients.
“We are learning more every day about how small amounts of prism can create tremendous symptom relief for patients,” says Vivek Labhishetty BSc Optometry, MSc, PhD, Director of Clinical Research for Neurolens. “This creates an imperative to ensure prism measurements can be entered with a high degree of specificity to maximize the number of patients that can be helped by this technology.”